Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Intravacc has partnered with contract development and manufacturing organisation (CDMO) Celonic Group for the design, development and production of a Covid-19 vaccine.
The vaccine will be based on an immunogenic Spike (S) protein of SARS-CoV-2 andIntravacc’s Outer Membrane Vesicle (OMV) technology.
Intravacc’s OMV platform will be combined with S-proteins expressed by Celonic’s CHOvolution mammalian cell expression system.